In an interview with Technology Networks, Dr. Daniel Reker discusses how machine learning is improving data-scarce areas of drug discovery.
Explore the impact of AI in drug discovery as 2026 promises critical clinical results and industry transformations.
Antimicrobial resistance (AMR) is diminishing the effectiveness of existing antibiotics and intensifying the need for discovery pipelines that are both ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--insitro, a pioneer in machine learning for drug discovery and development, today announced a new collaboration with Eli Lilly and Company (Lilly) to ...
From antibiotic resistance to emerging viral threats, the global demand for new medicines is intensifying, yet traditional drug discovery pipelines remain slow and expensive. A new scientific review ...
Machine learning in drug discovery, along with artificial intelligence, is transforming the pharmaceutical industry by accelerating the development of new treatments. Historically, the process of ...
Explore the innovative concept of vibe coding and how it transforms drug discovery through natural language programming.
The drug development pipeline is a costly and lengthy process. Identifying high-quality "hit" compounds-those with high potency, selectivity, and favorable metabolic properties-at the earliest stages ...
HYDERABAD, India--(BUSINESS WIRE)--Aurigene Pharmaceutical Services Limited (Aurigene), a contract research, development, and manufacturing services organization and a Dr. Reddy’s Laboratories company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results